Value-Based Cancer Care Issues

October 2015, Vol 6, No 9

An Accountable Payment Model a “Win-Win-Win” Solution to Value-Based Care

Wayne Kuznar

AVBCC 2015 5th Annual Conference

The Triple Aim of better patient care, lower spending by payers, and the maintenance of financially viable practices and hospitals is achievable with condition-based payment models in oncology, said Harold D. Miller, MS, President and Chief Executive Officer, Center for Healthcare Quality and Payment Reform, at the Fifth Annual Conference of the Association for Value-­Based Cancer Care. [ Read More ]

FDA News – October 2015

FDA Approvals, News & Updates

  • A Turning Point in Cancer Therapy: First Combination of 2 Immunotherapies Approved for Advanced Melanoma
  • Another Immunotherapy, Keytruda, Approved for Metastatic Lung Cancer Together with a Companion Diagnostic
  • Lonsurf, a New Oral Combination, Approved for Patients with Metastatic Colorectal Cancer
  • Emend Receives Expanded Indication for CINV Prevention in Pediatric Patients
[ Read More ]

NEXT Study: Biosimilar Filgrastim an Effective Alternative for Chemotherapy-Induced Neutropenia

Meg Barbor, MPH

Emerging Therapies

Copenhagen, Denmark—Biosimilar filgrastim (Nivestim; Hospira), which was approved earlier this year by the European Commission but not yet by the FDA, showed effectiveness for the treatment of neutropenia and febrile neutropenia (FN) in patients undergoing cytotoxic chemotherapy for solid tumors and hematologic malignancies, according to a study presented at the 2015 Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology meeting. [ Read More ]

In the Literature – October 2015

In the Literature

  • Bevacizumab for Advanced Lung Cancer Does Not Increase Risk for Hospitalization or Unexpected Toxicity
  • Early Palliative Care for Patients with Advanced Cancer Greatly Increases Cost-Savings
  • Daratumumab, an Anti-CD38 Monoclonal Antibody, Effective Treatment Option for Patients with Relapsed and/or Refractory Multiple Myeloma
[ Read More ]